Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

The U.S. Food and Drug Administration (FDA) has granted market clearance for AstraZeneca's dapagliflozin (Farxiga) to reduce the risk of hospitalization for heart failure (HF) in adults with type 2 diabetes (T2D) and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors.
Feature | Heart Failure | Dave Fornell, Editor

October 21, 2019 – The U.S. Food and Drug Administration (FDA) has granted market clearance for AstraZeneca's ...

Home October 21, 2019
Home
News | Heart Failure

October 16, 2019 — Researchers have shown for the first time in preclinical studies that the drug Aliskiren can delay ...

Home October 16, 2019
Home
News | Heart Failure

October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...

Home October 04, 2019
Home
News | Heart Failure

October 3, 2019 – The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...

Home October 03, 2019
Home
Blog | University of Colorado Hospital

I recently had the opportunity to conduct an onsite visit to the University of Colorado Hospital Heart and Vascular ...

Home October 02, 2019
Home
News | Heart Failure

September 27, 2019 — Ancora Heart Inc. announced results from an interim analysis of heart failure patients treated in ...

Home September 27, 2019
Home
News | Heart Failure

September 20, 2019 — The new Max and Debra Ernst Heart Center at Beaumont Hospital, Royal Oak, Mich., will open Sept. 30 ...

Home September 20, 2019
Home
News | Heart Failure

September 18, 2019 — AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

Home September 18, 2019
Home
News | Heart Failure

September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a heart failure (HF) device ...

Home September 12, 2019
Home
News | Heart Failure

September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse, but ...

Home September 11, 2019
Home
News | Heart Failure

September 11, 2019 — The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint of ...

Home September 11, 2019
Home
News | Heart Failure

September 9, 2019 — AstraZeneca announced detailed results from the landmark Phase III DAPA-HF trial that showed Farxiga ...

Home September 09, 2019
Home
News | Cardiac Imaging

September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along ...

Home September 09, 2019
Home
News | Heart Failure

September 9, 2019 — The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart ...

Home September 09, 2019
Home
Subscribe Now